Coagulanolide modulates hepatic glucose metabolism in C57BL/KsJ-db/db mice

Human and Experimental Toxicology

Volumn 31, Issue 10, 2012, Pages 1056-1065

  Singh, A B ^a   Singh, N ^b   Akanksha, ^a   Jayendra, ^a   Maurya, R ^a   Srivastava, A K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b G B PANT UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

Author keywords

antidiabetic; coagulanolide; db db mice; hepatic glucose metabolism; Withania coagulans

Indexed keywords

ANTIDIABETIC AGENT; COAGULANOLIDE; FATTY ACID; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN PHOSPHORYLASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WITHANIA;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENZYMES; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; TIME FACTORS; WITHANOLIDES;

EID: 84867564765     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112438289     Document Type: Article

References (29)

1. Hundal RS, Krssak M, Dufour S, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000 ; 49: 2063-2069
2. Latha P, Pushpangadan P. Effec't of Withania coagulans fruit extract on blood glucose levels of normal and alloxan-diabetic rats. J Trop Med Plants. 2002 ; 3: 181-186
3. Budhiraja RD, Garg KN, Sudhir S, Arora B. Protective effect of 3-beta-hydroxy-2, 3-dihydrowithanolide F against CCl4-induced hepatotoxicity. Planta Med. 1986 ; (1). 28-29
4. Hemalatha S, Wahi AK, Singh PN, Chansouria JP. Hypoglycemic activity of Withania coagulans Dunal in streptozotocin induced diabetic rats. J Ethnopharmacol. 2004 ; 93: 261-264
5. Hemalatha S, Wahi AK, Singh PN, Chansouria JP. Hypolipidemic activity of aqueous extract of Withania coagulans Dunal in albino rats. Phytotherapy Res. 2006 ; 20: 614-617
6. Prasad SK, Kumar R, Patel DK, Hemalatha S. Wound healing activity of Withania coagulans in streptozotocin-induced diabetic rats. Pharmaceutical Biol. 2010 ; 48: 1397-1404
7. Maurya R, Akanksha Jayendra, Singh AB, Srivastava AK. Coagulanolide, a withanolide from Withania coagulans fruits and antihyperglycemic activity. Bioorg Med Chem Lett. 2008 ; 18: 6534-6537
8. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science. 1966 ; 153: 1127-1128
9. Park CW, Kim HW, Ko SH, et al. Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. J Am Soc Nephrol. 2007 ; 18: 1227-1238
10. Nishina PM, Lowe S, Wang J, Paigen B. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism. 1994 ; 43: 549-553
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 ; 193: 265-275
12. Porter EV, Chassy BM. Glucokinase from Streptococcus mutans. Methods Enzymol. 1982 ; 90 (pt E). 25-30
13. Buchner T, Pfleiderer G Methods enzymol. Colowick SP Kaplan NO, ed. London: Academic Press ; 1955: 435-440.
14. Berthet J, Rall TW, Sutherland EW. The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J Biol Chem. 1957 ; 224: 463-475
15. Taussky HH, Shorr E. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem. 1953 ; 202: 675-685
16. Hubscher G, West GR, Brindley DN. Studies on the fractionation of mucosal homogenates from the small intestine. Biochem J. 1965 ; 97: 629-642
17. Ulm EH, Pogell BM, De Maine MM, Libby CB, Benkovic SJ. Fructose-1, 6-diphosphatase from rabbit liver. Methods Enzymol. 1975 ; 42: 369-374
18. Ward CW, Castro GA, Fairbairn D. Carbon dioxide fixation and phosphoenolpyruvate metabolism in Trichinella spiralis larvae. J Parasitol. 1969 ; 55: 67-71
19. Basu A, Basu R, Shah P, et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 2000 ; 49: 272-283
20. Krssak M, Brehm A, Bernroider E, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes. 2004 ; 53: 3048-3056
21. Brocklehurst KJ, Payne VA, Davies RA, et al. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes. 2004 ; 53: 535-541
22. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition. 1997 ; 13: 65
23. Davies GF, Khandelwal RL, Wu L, Juurlink BH, Roesler WJ. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem Pharmacol. 2001 ; 62: 1071-1079
24. Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem. 2007 ; 14: 1729-1738
25. Hawkins M, Tonelli J, Kishore P, et al. Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes. Diabetes. 2003 ; 52: 2748-2758
26. Shah P, Vella A, Basu A, et al. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes. 2003 ; 52: 38-42
27. Santomauro AT, Boden G, Silva ME. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999 ; 48: 1836-1841
28. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care. 2002 ; 5: 545-549
29. Wilson PW. High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am J Cardiol. 1990 ; 66: 7A - 10A